Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
23-31 |
SP_7 |
denotes |
COVID-19 |
T2 |
103-111 |
SP_7 |
denotes |
COVID-19 |
T3 |
134-142 |
SP_7 |
denotes |
COVID-19 |
T4 |
225-229 |
UBERON:0000104 |
denotes |
life |
T5 |
288-293 |
CHEBI:23888 |
denotes |
drugs |
T6 |
288-293 |
CHEBI:23888 |
denotes |
drugs |
T7 |
432-448 |
CHEBI:50846 |
denotes |
immunomodulating |
T8 |
432-448 |
CHEBI:50846 |
denotes |
immunomodulating |
T9 |
496-504 |
SP_7 |
denotes |
COVID-19 |
T10 |
655-663 |
SP_7 |
denotes |
COVID-19 |
T11 |
711-717 |
CHEBI:36357 |
denotes |
agents |
T12 |
711-717 |
CHEBI:36357 |
denotes |
agents |
T13 |
908-919 |
CHEBI:3638 |
denotes |
chloroquine |
T14 |
908-919 |
DG_10 |
denotes |
chloroquine |
T15 |
908-919 |
CHEBI:3638 |
denotes |
chloroquine |
T16 |
921-939 |
CHEBI:5801 |
denotes |
hydroxychloroquine |
T17 |
921-939 |
DG_20 |
denotes |
hydroxychloroquine |
T18 |
921-939 |
CHEBI:5801 |
denotes |
hydroxychloroquine |
T19 |
941-950 |
CHEBI:31781 |
denotes |
lopinavir |
T20 |
941-950 |
DG_23 |
denotes |
lopinavir |
T21 |
941-950 |
CHEBI:31781 |
denotes |
lopinavir |
T22 |
951-960 |
DG_30 |
denotes |
ritonavir |
T23 |
951-960 |
NCBITaxon:7729 |
denotes |
ritonavir |
T24 |
962-973 |
DG_17 |
denotes |
favipiravir |
T25 |
962-973 |
NCBITaxon:31032 |
denotes |
favipiravir |
T26 |
978-988 |
DG_28 |
denotes |
remdesivir |
T27 |
978-988 |
NCBITaxon:11632 |
denotes |
remdesivir |
T28 |
1012-1024 |
CHEBI:17154 |
denotes |
Nitazoxanide |
T29 |
1012-1024 |
CHEBI:17154 |
denotes |
Nitazoxanide |
T30 |
1138-1148 |
SP_7 |
denotes |
SARS-CoV-2 |
T31 |
1207-1212 |
SP_6 |
denotes |
human |
T32 |
1207-1212 |
NCBITaxon:9606 |
denotes |
human |